Author:
Miligy Islam M.,Toss Michael S.,Gorringe Kylie L.,Lee Andrew H. S.,Ellis Ian O.,Green Andrew R.,Rakha Emad A.
Funder
Ministry of Higher education and scientific research - Egypt
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Lari, S. A. & Kuerer, H. M. Biological markers in DCIS and risk of breast recurrence: a systematic review. J. Cancer 2, 232–261 (2011).
2. Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol. 1, 888–896 (2015).
3. Rakovitch, E., Nofech-Mozes, S., Hanna, W., Baehner, F. L., Saskin, R., Butler, S. M. et al. A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone. Breast Cancer Res. Treat. 152, 389–398 (2015).
4. Bartlett, J. M., Nofech-Moses, S. & Rakovitch, E. Ductal carcinoma in situ of the breast: can biomarkers improve current management? Clin. Chem. 60, 60–67 (2014).
5. Fleischer, T., Frigessi, A., Johnson, K. C., Edvardsen, H., Touleimat, N., Klajic, J. et al. Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis. Genome Biol. 15, 435 (2014).
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献